Does Fasting Help Arthritis? What the Research Says

Fasting does appear to reduce arthritis symptoms in the short term, particularly for rheumatoid arthritis, but the picture is more complicated than a simple yes. Clinical trials and observational studies consistently show drops in inflammatory markers and disease activity scores during fasting periods, yet most studies are small, run for only weeks to months, and leave open the question of whether these improvements hold up over time.¹ The type of arthritis matters enormously too, because fasting can actually worsen gout by driving uric acid levels up.

The Trial That Put Fasting on the Map

The most-cited study on fasting and arthritis was published in The Lancet in 1991. Researchers in Norway put rheumatoid arthritis patients through a 7- to 10-day near-total fast, then transitioned them to a gluten-free vegan diet for about three and a half months, and finally to a vegetarian diet for the rest of the year. The results were striking: after just four weeks, the fasting-then-diet group showed improvements across the board, including fewer tender and swollen joints, less morning stiffness, stronger grip, and lower levels of C-reactive protein (CRP) and erythrocyte sedimentation rate, both standard markers of inflammation. The control group, which ate a normal diet at a convalescent home, saw almost none of those gains. Crucially, the improvements in the diet group were still present a full year later.²

That trial is over three decades old now, and it set an important precedent, but it also left a frustrating ambiguity: was it the fasting itself that helped, or the year-long vegetarian diet that followed? Most researchers today think both contributed, but the study design makes it impossible to tease them apart cleanly. This has been a recurring problem in the field. The fasting component and the dietary shift that follows are usually bundled together, making it hard to say exactly how much credit fasting alone deserves.

What Ramadan Fasting Studies Reveal

Ramadan provides a natural experiment. During the month of Ramadan, observant Muslims fast from dawn to sunset, roughly matching a 16:8 intermittent fasting pattern. Several research groups have studied RA patients who choose to fast during this period, comparing them with RA patients who do not.

A study out of Pakistan found that disease activity scores dropped in both fasting and non-fasting RA patients during Ramadan, but post-Ramadan scores were lower in the fasting group. The researchers concluded that RA patients with moderate disease activity could safely fast without fear of their condition flaring.³ A Turkish study reported that fasting lowered average disease activity scores and reduced morning stiffness, though some of the improvements did not reach statistical significance in that sample.⁴

A systematic review and meta-analysis that pooled both observational studies and randomized controlled trials on intermittent fasting for rheumatic diseases found that observational data showed fairly large improvements in both pain and disease activity scores. When restricted to randomized trials only, the effect on disease activity was smaller but still statistically significant.⁵ The gap between observational and randomized data is telling. People who choose to fast may also be healthier, more motivated, or have milder disease to begin with, which inflates the apparent benefit in observational studies.

How Fasting Dials Down Inflammation

The most consistent finding across fasting studies is a reduction in CRP, the blood marker doctors use to gauge systemic inflammation. A meta-analysis of randomized controlled trials found that intermittent fasting regimens lowered CRP, and that the effect was more pronounced in people who were overweight or obese and in studies lasting at least eight weeks.⁶ That same meta-analysis, though, found no significant effect on two other important inflammatory signals, tumor necrosis factor-alpha and interleukin-6. So fasting does not suppress all inflammatory pathways equally.

A study of healthy people fasting during Ramadan did report significant drops in IL-1β, IL-6, and TNF-α during the fasting month compared to before and after, along with reductions in body fat and white blood cell counts.⁷ Why would one study see cytokine drops and a meta-analysis not? Population differences likely explain part of it: healthy subjects during Ramadan versus a mix of clinical populations with different baseline inflammation levels. The takeaway is that fasting reliably lowers CRP, and may lower other inflammatory markers too, but the evidence is less consistent for those.

Ketones and the Inflammasome

One of the more compelling explanations for fasting’s anti-inflammatory effect involves a metabolic byproduct called beta-hydroxybutyrate, or BHB. When you fast, your liver starts producing BHB as an alternative fuel source. In a widely cited study published in Nature Medicine, researchers showed that BHB directly blocks a molecular complex called the NLRP3 inflammasome, which is a key driver of inflammation in several diseases, including gout. BHB suppressed the inflammasome’s response to urate crystals, the exact trigger for gout flares.⁸ Follow-up research confirmed that BHB deactivates the NLRP3 inflammasome specifically in neutrophils, the immune cells that swarm into joints during a gout attack, by disrupting both the priming and assembly steps of the inflammatory cascade.⁹

This is an elegant mechanism on paper, but it creates a paradox for gout specifically, which we will get to shortly.

What About Osteoarthritis?

Most fasting-and-arthritis research focuses on rheumatoid arthritis, which is an autoimmune disease driven by the immune system attacking joint tissue. Osteoarthritis is a different beast: it involves the gradual breakdown of cartilage, driven partly by mechanical wear and partly by metabolic and inflammatory processes. The evidence for fasting and OA is less developed but growing.

Preclinical studies suggest intermittent fasting may help OA through several routes: improving metabolic profiles, reducing inflammation in and around the joint, activating autophagy (the cell’s internal cleanup process), and shifting gut bacteria in a favorable direction.¹⁰ One animal study found that fasting activated a specific type of cellular recycling in cartilage cells, which helped maintain healthy mitochondria and reduced the severity of surgically induced OA in mice. The fasting mice had less joint damage on imaging and lower cartilage-damage scores compared to mice that did not fast.¹¹

The metabolic angle is worth paying attention to. Insulin resistance, the condition where cells stop responding well to insulin, is closely linked to OA. It fuels low-grade systemic inflammation, disrupts normal immune activity in the joint lining, and accelerates cartilage damage.¹² The pathways overlap with those seen in type 2 diabetes: excess fatty acids interfere with insulin signaling, glucose builds up inside cells, and the resulting metabolic dysfunction spills over into joint tissue.¹³ Since intermittent fasting is known to improve insulin sensitivity and metabolic health, there is a plausible case that it could slow OA progression through this route. But the human clinical evidence for that specific chain of events is still thin.

The Gout Exception

If you have gout, fasting deserves a warning label. Research dating back to the 1960s showed that even one or two days of fasting caused appreciable rises in serum uric acid. The mechanism: when you fast, ketone levels rise, and those ketones compete with uric acid for excretion through the kidneys. The result is that less uric acid gets flushed out, and blood levels climb.¹⁴

This creates a frustrating contradiction. On one hand, the ketone BHB produced during fasting blocks the very inflammasome pathway that drives gout flares. On the other hand, the same metabolic shift that produces BHB also raises uric acid, the substance that triggers those flares in the first place. For someone with established gout or borderline-high uric acid levels, the net effect of fasting could easily be negative, provoking an acute attack rather than preventing one. This is one area where the theoretical anti-inflammatory benefits of fasting collide head-on with a real metabolic risk.

Gut Bacteria and Joint Inflammation

An emerging line of research looks at fasting’s effect on the gut microbiome and how that feeds back into joint health. In a mouse model of rheumatoid arthritis, intermittent fasting increased the diversity and abundance of gut bacteria, and specifically boosted populations of anti-inflammatory bacteria in the Ruminococcaceae family. These microbial shifts accompanied reductions in joint inflammation and damage.¹⁵ Gut-joint connections have received increasing attention in rheumatology, since the gut lining serves as a barrier that, when compromised, can allow bacterial products to enter the bloodstream and trigger immune responses far from the intestine. How much of fasting’s benefit in RA is direct anti-inflammatory action versus an indirect effect through the gut remains an open question, and it is unlikely to be either/or.

How Long Do the Benefits Last?

One of the most practical questions is whether the improvements seen during fasting persist once you start eating normally again. A study that tracked RA patients through Ramadan and for three months afterward found that the drops in CRP, ESR, and disease activity scores achieved during fasting were still present at the three-month mark, though CRP had started creeping back up. The authors suggested that repeating a fasting period roughly every three months might be needed to maintain the benefits.¹⁶

A 2025 narrative review of fasting and caloric restriction in RA came to a similar, cautious conclusion: while short-term improvements in disease activity and inflammatory markers are fairly well documented, long-term efficacy remains uncertain because most studies simply do not last long enough to tell.¹ The 1991 Lancet trial, which followed patients for a year, remains one of the longest. And in that study, the fasting period was only the first week or so; the sustained benefit was maintained by an ongoing vegetarian diet.² This suggests that periodic fasting alone, without a lasting change in eating patterns, probably has a ceiling on what it can deliver.

Risks Worth Knowing About

Fasting is not risk-free, and the risks shift depending on who you are and what type of arthritis you have.

Muscle loss: For older adults, prolonged daily fasting windows can impair muscle protein synthesis and worsen age-related muscle loss. Since muscle supports and stabilizes joints, losing it can undermine the very joints you are trying to protect.¹⁷ Getting enough protein during eating windows is critical for anyone with arthritis who wants to try intermittent fasting.
Medication timing: Many arthritis drugs need to be taken with food to protect the stomach or to be absorbed properly. Methotrexate, corticosteroids, and nonsteroidal anti-inflammatory drugs all have specific dosing requirements that may clash with a restricted eating window. Anyone on arthritis medication should coordinate fasting plans with their prescribing doctor rather than improvise.
Gout flares: As discussed, fasting raises uric acid and can provoke acute gout attacks. People with gout or hyperuricemia should be especially cautious about extended fasts.
Refeeding rebound: Some patients report worsening symptoms after breaking a fast, particularly if they return to inflammatory foods. The Ramadan data showing a gradual climb in CRP after the fasting month ends hints at this pattern.

A randomized trial of 16:8 intermittent fasting in postmenopausal, overweight women with RA found improvements in oxidative stress markers, a key inflammatory index, and liver enzyme levels, all without reported adverse effects.¹⁸ But that was a specific group: overweight postmenopausal women. Extrapolating those results to a 30-year-old man with ankylosing spondylitis, or a 75-year-old woman with knee OA, is a stretch.

Fasting-Mimicking Diets and Pain Pathways

Not everyone can or wants to do a full fast, which has driven interest in fasting-mimicking diets. These are very-low-calorie regimens (typically around 800 calories per day for several days) that aim to trigger the same metabolic shifts as fasting while still allowing some food intake. Research on their potential in autoimmune diseases has explored how the type and amount of nutrients consumed can influence immune cell behavior.¹⁹

One intriguing animal study found that a fasting-mimicking diet reduced inflammatory pain through a mechanism that goes beyond just lowering cytokines. It inhibited the formation of neutrophil extracellular traps, web-like structures that neutrophils release to catch pathogens but that also amplify inflammation, and it reduced neuroinflammation in the spinal cord.²⁰ If this holds up in humans, it would mean fasting-type diets could dampen pain not just by reducing joint inflammation but by changing how the nervous system processes pain signals. That is a fundamentally different avenue, and one that could matter for the many arthritis patients whose pain levels seem out of proportion to visible joint damage on imaging.

Why the Evidence Feels So Incomplete

If fasting can do all these things, why haven’t rheumatologists embraced it? The honest answer is that the research base, while growing, is still frustratingly small. Most trials have fewer than 100 participants. Many are observational, meaning people self-select into fasting, introducing bias. Blinding is nearly impossible since you obviously know whether you are eating or not. And fasting protocols vary wildly across studies: 7-day water fasts, 16:8 daily time restriction, Ramadan dawn-to-dusk fasting, and fasting-mimicking diets all get lumped together as “fasting” even though they impose very different metabolic stresses.

The meta-analysis that pooled randomized trial data for rheumatic diseases found a statistically significant reduction in disease activity, but it was based on just two independent trials totaling 94 participants.⁵ That is a razor-thin evidence base for any clinical recommendation. And for osteoarthritis, the most common form of arthritis worldwide, the human data is even sparser, relying heavily on animal models and mechanistic reasoning. The science is genuinely promising, but it has not yet crossed the threshold where you would call it definitive. For most people with arthritis, fasting is more accurately described as a plausible complementary approach than a proven treatment, and one that works best when layered on top of conventional medical care rather than substituted for it.